Press Releases September 2, 2026 04:05 PM

Option Care Health to Participate in Upcoming Investor Conferences

Option Care Health executives to participate in major healthcare investor conferences in September 2026

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
OPCH

Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., announced that its CEO and CFO will present at the Morgan Stanley Global Healthcare Conference and Deutsche Bank Healthcare Summit in September 2026. The company aims to share its business outlook and strategies with investors during these conferences.

Option Care Health to Participate in Upcoming Investor Conferences
OPCH
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Option Care Health is the largest independent home and alternate site infusion services provider in the U.S.
  • CEO John Rademacher and CFO Meenal Sethna will present at two major healthcare investor conferences in New York City.
  • Company highlights its national scale with over 8,000 team members and commitment to elevating infusion care across all 50 states.

BANNOCKBURN, Ill., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced that John Rademacher, CEO and Meenal Sethna, CFO, will participate in the following up coming investor conferences:

  • Morgan Stanley 24th Annual Global Healthcare Conference, being held in New York City, on Tuesday, September 15, 2026 at 10:45am ET/9:45am CT.
  • Deutsche Bank 2026 Healthcare Summit, being held in New York City, Wednesday, September 16, 2026.

Webcast links and related presentation materials, if applicable, will be available online at https://investors.optioncarehealth.com.

About Option Care Health

Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 8,000 team members including more than 5,000 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn more, please visit our website at optioncarehealth.com.

For Investor Inquiries:

Bob Okunski
Vice President, Investor Relations
[email protected] 


Risks

  • Market reaction to the presentations is uncertain and may not impact stock price significantly, resulting in a neutral effect.
  • Competitive pressures in the healthcare and infusion services sector could affect business growth prospects.
  • Regulatory changes in healthcare and infusion services could pose operational risks.

More from Press Releases

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer Sep 2, 2026 BioRestorative Therapies Announces Reverse Stock Split Sep 2, 2026 Capital Southwest Increases Corporate Credit Facility to $595 million and Extends Maturity to September 2031 Sep 2, 2026 Archimedes Tech SPAC Partners II Co. Announces Filing of Third Amendment to Registration Statement on Form S-4 with the SEC Sep 2, 2026 Sprott Focus Trust, Inc. (Nasdaq-FUND) Declares Third Quarter Common Stock Distribution of $0.1503 Per Share Sep 2, 2026